Last Updated：2025/11/30
In the Phase III study, finerenone significantly improved outcomes in patients with chronic heart failure and reduced the rate of hospital readmissions.
See correct answer
In the Phase III study, finerenone significantly improved outcomes in patients with chronic heart failure and reduced the rate of hospital readmissions.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
